ILMN has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ILMN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2024-05-14), Illumina's current share price is $115.58. Illumina's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was $4.27. Illumina's Cyclically Adjusted Price-to-FCF for today is 27.07.
The historical rank and industry rank for Illumina's Cyclically Adjusted Price-to-FCF or its related term are showing as below:
During the past years, Illumina's highest Cyclically Adjusted Price-to-FCF was 212.26. The lowest was 22.25. And the median was 98.10.
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.
Illumina's adjusted free cash flow per share data for the three months ended in Mar. 2024 was $0.258. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is $4.27 for the trailing ten years ended in Mar. 2024.
The historical data trend for Illumina's Cyclically Adjusted Price-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Illumina Quarterly Data | ||||||||||||||||||||
Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Cyclically Adjusted Price-to-FCF | Get a 7-Day Free Trial | 55.43 | 44.56 | 32.35 | 32.72 | 32.19 |
For the Diagnostics & Research subindustry, Illumina's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Diagnostics & Research industry and Healthcare sector, Illumina's Cyclically Adjusted Price-to-FCF distribution charts can be found below:
* The bar in red indicates where Illumina's Cyclically Adjusted Price-to-FCF falls into.
Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.
Illumina's Cyclically Adjusted Price-to-FCF for today is calculated as
Cyclically Adjusted Price-to-FCF | = | Share Price | / | Cyclically Adjusted FCF per Share |
= | 115.58 | / | 4.27 | |
= | 27.07 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Illumina's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:
For example, Illumina's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:
Adj_FreeCashFlowPerShare | = | Free Cash Flow per Share | / | CPI of Mar. 2024 (Change) | * | Current CPI (Mar. 2024) |
= | 0.258 | / | 129.4194 | * | 129.4194 | |
= | 0.258 |
Current CPI (Mar. 2024) = 129.4194.
Illumina Quarterly Data
Free Cash Flow per Share | CPI | Adj_FreeCashFlowPerShare | |
201406 | 1.037 | 100.560 | 1.335 |
201409 | 0.750 | 100.428 | 0.967 |
201412 | 0.513 | 99.070 | 0.670 |
201503 | 0.203 | 99.621 | 0.264 |
201506 | 0.871 | 100.684 | 1.120 |
201509 | 1.012 | 100.392 | 1.305 |
201512 | 2.229 | 99.792 | 2.891 |
201603 | 0.311 | 100.470 | 0.401 |
201606 | 1.176 | 101.688 | 1.497 |
201609 | 0.730 | 101.861 | 0.928 |
201612 | 1.216 | 101.863 | 1.545 |
201703 | 0.578 | 102.862 | 0.727 |
201706 | 0.741 | 103.349 | 0.928 |
201709 | 1.020 | 104.136 | 1.268 |
201712 | 1.473 | 104.011 | 1.833 |
201803 | 1.115 | 105.290 | 1.371 |
201806 | 1.473 | 106.317 | 1.793 |
201809 | 1.530 | 106.507 | 1.859 |
201812 | 1.546 | 105.998 | 1.888 |
201903 | 0.953 | 107.251 | 1.150 |
201906 | 0.644 | 108.070 | 0.771 |
201909 | 1.473 | 108.329 | 1.760 |
201912 | 2.591 | 108.420 | 3.093 |
202003 | 1.628 | 108.902 | 1.935 |
202006 | 1.358 | 108.767 | 1.616 |
202009 | 0.709 | 109.815 | 0.836 |
202012 | 2.324 | 109.897 | 2.737 |
202103 | 1.633 | 111.754 | 1.891 |
202106 | 1.422 | 114.631 | 1.605 |
202109 | -2.118 | 115.734 | -2.368 |
202112 | 1.350 | 117.630 | 1.485 |
202203 | 0.698 | 121.301 | 0.745 |
202206 | 0.344 | 125.017 | 0.356 |
202209 | -1.898 | 125.227 | -1.962 |
202212 | 0.376 | 125.222 | 0.389 |
202303 | -0.272 | 127.348 | -0.276 |
202306 | 0.367 | 128.729 | 0.369 |
202309 | 0.595 | 129.860 | 0.593 |
202312 | 1.095 | 129.419 | 1.095 |
202403 | 0.258 | 129.419 | 0.258 |
Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.
Thank you for viewing the detailed overview of Illumina's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
Aimee L Hoyt | officer: SVP, Chief People Officer | 5200 ILLUMINA WAY, SAN DIEGO CA 92122 |
Jacob Thaysen | director, officer: Chief Executive Officer | 5301 STEVENS CREEK BLVD., SANTA CLARA CA 95051 |
Susan H Tousi | officer: SVP Product Development | 5200 ILLUMINA WAY, SAN DIEGO CA 92122 |
Steven Barnard | officer: SVP, Chief Technology Officer | 5200 ILLUMINA WAY, SAN DIEGO CA 92122 |
Scott B. Ullem | director | C/O EDWARDS LIFESCIENCES CORPORATION, ONE EDWARDS WAY, IRVINE CA 92614 |
Stephen P Macmillan | director | 250 CAMPUS DRIVE, MARLBOROUGH MA 01752 |
Andrew Teno | director | C/O FIR TREE INC., 55 WEST 46TH STREET, 29TH FLOOR, NEW YORK NY 10036 |
Alexander Aravanis | officer: SVP, Chief Technology Officer | 5200 ILLUMINA WAY, SAN DIEGO CA 92122 |
Scott D Ericksen | officer: VP, Chief Accounting Officer | 5200 ILLUMINA WAY, SAN DIEGO CA 92122 |
Charles Dadswell | officer: Sr VP & General Counsel | 5200 ILLUMINA WAY, SAN DIEGO CA 92122 |
John Edward Frank | officer: Chief Public Affairs Officer | 5200 ILLUMINA WAY, SAN DIEGO CA 92122 |
Phillip G. Febbo | officer: SVP Chief Medical Officer | C/O GENOMIC HEALTH, INC., 301 PENOBSCOT DRIVE, REDWOOD CITY CA 94063 |
Carissa Rollins | officer: SVP, Chief Information Officer | 5200 ILLUMINA WAY, SAN DIEGO CA 92122 |
Kevin Carl Pegels | officer: Chief of Global Operations | 5200 ILLUMINA WAY, SAN DIEGO CA 92122 |
Jay T Flatley | officer: President & CEO | 9885 TOWNE CENTRE DR, SAN DIEGO CA 92121 |
From GuruFocus
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024